
Nghi V. Nguyen
Examiner (ID: 18988, Phone: (571)270-3055 , Office: P/1653 )
| Most Active Art Unit | 1653 |
| Art Unit(s) | 1653 |
| Total Applications | 580 |
| Issued Applications | 260 |
| Pending Applications | 79 |
| Abandoned Applications | 254 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 16778306
[patent_doc_number] => 20210115384
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-22
[patent_title] => SYSTEMS AND METHODS FOR CELL CULTURING
[patent_app_type] => utility
[patent_app_number] => 17/074902
[patent_app_country] => US
[patent_app_date] => 2020-10-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15596
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17074902
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/074902 | Systems and methods for cell culturing | Oct 19, 2020 | Issued |
Array
(
[id] => 20804593
[patent_doc_number] => 12669496
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-06-30
[patent_title] => Method for evaluating and/or screening a control agent for tissue morphology and/or tissue function
[patent_app_type] => utility
[patent_app_number] => 17/793184
[patent_app_country] => US
[patent_app_date] => 2020-10-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 4587
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 102
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17793184
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/793184 | Method for evaluating and/or screening a control agent for tissue morphology and/or tissue function | Oct 18, 2020 | Issued |
Array
(
[id] => 18497677
[patent_doc_number] => 20230220346
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-13
[patent_title] => BIOLOGICALLY SYNTHESIZED HYDROXYAPATITE FOR BONE REGENERATION AND TISSUE ENGINEERING
[patent_app_type] => utility
[patent_app_number] => 17/769663
[patent_app_country] => US
[patent_app_date] => 2020-10-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13659
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17769663
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/769663 | BIOLOGICALLY SYNTHESIZED HYDROXYAPATITE FOR BONE REGENERATION AND TISSUE ENGINEERING | Oct 15, 2020 | Pending |
Array
(
[id] => 20451835
[patent_doc_number] => 12514879
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-01-06
[patent_title] => Use of acellular adipose tissue extract in promoting hair growth and retention
[patent_app_type] => utility
[patent_app_number] => 17/768587
[patent_app_country] => US
[patent_app_date] => 2020-10-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 1922
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 201
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17768587
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/768587 | Use of acellular adipose tissue extract in promoting hair growth and retention | Oct 15, 2020 | Issued |
Array
(
[id] => 17005401
[patent_doc_number] => 20210236562
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-05
[patent_title] => COMPOSITIONS FOR THE TREATMENT OF SKIN CONDITIONS
[patent_app_type] => utility
[patent_app_number] => 17/067560
[patent_app_country] => US
[patent_app_date] => 2020-10-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14001
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17067560
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/067560 | COMPOSITIONS FOR THE TREATMENT OF SKIN CONDITIONS | Oct 8, 2020 | Abandoned |
Array
(
[id] => 16748850
[patent_doc_number] => 20210100859
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-08
[patent_title] => HERPES SIMPLEX VIRUS (HSV) ANTICANCER THERAPIES
[patent_app_type] => utility
[patent_app_number] => 17/066162
[patent_app_country] => US
[patent_app_date] => 2020-10-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13380
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17066162
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/066162 | HERPES SIMPLEX VIRUS (HSV) ANTICANCER THERAPIES | Oct 7, 2020 | Abandoned |
Array
(
[id] => 19731279
[patent_doc_number] => 12209270
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-01-28
[patent_title] => Kit and method
[patent_app_type] => utility
[patent_app_number] => 17/641774
[patent_app_country] => US
[patent_app_date] => 2020-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 25
[patent_no_of_words] => 10526
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 214
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17641774
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/641774 | Kit and method | Sep 8, 2020 | Issued |
Array
(
[id] => 18962937
[patent_doc_number] => 11896676
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-02-13
[patent_title] => Targeting cancer cells and tissue using filamentous plant virus particles
[patent_app_type] => utility
[patent_app_number] => 16/988210
[patent_app_country] => US
[patent_app_date] => 2020-08-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 19
[patent_no_of_words] => 14819
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 131
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16988210
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/988210 | Targeting cancer cells and tissue using filamentous plant virus particles | Aug 6, 2020 | Issued |
Array
(
[id] => 16468488
[patent_doc_number] => 20200370025
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-11-26
[patent_title] => Acute Respiratory Distress Syndrome Therapeutic Agent
[patent_app_type] => utility
[patent_app_number] => 16/984793
[patent_app_country] => US
[patent_app_date] => 2020-08-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8144
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 103
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16984793
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/984793 | Acute respiratory distress syndrome therapeutic agent | Aug 3, 2020 | Issued |
Array
(
[id] => 17792408
[patent_doc_number] => 20220251499
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-11
[patent_title] => IMPROVED BUFFER FOR THE CAPACITATION OF SPERMATOZOA
[patent_app_type] => utility
[patent_app_number] => 17/597606
[patent_app_country] => US
[patent_app_date] => 2020-07-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3464
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17597606
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/597606 | IMPROVED BUFFER FOR THE CAPACITATION OF SPERMATOZOA | Jul 27, 2020 | Abandoned |
Array
(
[id] => 16883733
[patent_doc_number] => 20210169928
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-10
[patent_title] => Topical Exosome Compositions and Associated Methods
[patent_app_type] => utility
[patent_app_number] => 16/936090
[patent_app_country] => US
[patent_app_date] => 2020-07-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12131
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16936090
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/936090 | Topical Exosome Compositions and Associated Methods | Jul 21, 2020 | Pending |
Array
(
[id] => 17830422
[patent_doc_number] => 20220267726
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-25
[patent_title] => ORDERED PROCESSING OF BLOOD PRODUCTS TO PRODUCE THERAPEUTICALLY ACTIVE CELLS
[patent_app_type] => utility
[patent_app_number] => 17/627353
[patent_app_country] => US
[patent_app_date] => 2020-07-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30771
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -68
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17627353
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/627353 | ORDERED PROCESSING OF BLOOD PRODUCTS TO PRODUCE THERAPEUTICALLY ACTIVE CELLS | Jul 16, 2020 | Abandoned |
Array
(
[id] => 17990391
[patent_doc_number] => 20220356428
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-10
[patent_title] => PANCREAS-ON-A-CHIP AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/621403
[patent_app_country] => US
[patent_app_date] => 2020-07-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16876
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17621403
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/621403 | PANCREAS-ON-A-CHIP AND USES THEREOF | Jun 30, 2020 | Abandoned |
Array
(
[id] => 16581474
[patent_doc_number] => 20210015876
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-21
[patent_title] => USE OF PASTEURIZED AKKERMANSIA FOR TREATING METABOLIC DISORDERS
[patent_app_type] => utility
[patent_app_number] => 16/916399
[patent_app_country] => US
[patent_app_date] => 2020-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18312
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16916399
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/916399 | USE OF PASTEURIZED AKKERMANSIA FOR TREATING METABOLIC DISORDERS | Jun 29, 2020 | Abandoned |
Array
(
[id] => 16539357
[patent_doc_number] => 20200405770
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-31
[patent_title] => ADMINISTRATION OF FIBROBLASTS AND DERIVATIVES THEREOF FOR TREATMENT OF TYPE 2 DIABETES
[patent_app_type] => utility
[patent_app_number] => 16/913860
[patent_app_country] => US
[patent_app_date] => 2020-06-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16901
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16913860
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/913860 | ADMINISTRATION OF FIBROBLASTS AND DERIVATIVES THEREOF FOR TREATMENT OF TYPE 2 DIABETES | Jun 25, 2020 | Pending |
Array
(
[id] => 18275498
[patent_doc_number] => 11614437
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-03-28
[patent_title] => Devices, systems, and methods for evaluating cardiac parameters
[patent_app_type] => utility
[patent_app_number] => 16/913528
[patent_app_country] => US
[patent_app_date] => 2020-06-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 32
[patent_figures_cnt] => 77
[patent_no_of_words] => 15423
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 192
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16913528
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/913528 | Devices, systems, and methods for evaluating cardiac parameters | Jun 25, 2020 | Issued |
Array
(
[id] => 20674087
[patent_doc_number] => 12614607
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-04-28
[patent_title] => Cell culture methods and compositions
[patent_app_type] => utility
[patent_app_number] => 17/622396
[patent_app_country] => US
[patent_app_date] => 2020-06-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 10
[patent_no_of_words] => 36634
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 192
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17622396
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/622396 | Cell culture methods and compositions | Jun 25, 2020 | Issued |
Array
(
[id] => 20533843
[patent_doc_number] => 12550889
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-02-17
[patent_title] => Organ perfusion system and method
[patent_app_type] => utility
[patent_app_number] => 17/761074
[patent_app_country] => US
[patent_app_date] => 2020-05-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 9
[patent_no_of_words] => 2431
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 176
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17761074
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/761074 | Organ perfusion system and method | May 28, 2020 | Issued |
Array
(
[id] => 18172777
[patent_doc_number] => 11572474
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-02-07
[patent_title] => Compositions comprising lignocellulosic byproducts for tire ballasts and associated methods
[patent_app_type] => utility
[patent_app_number] => 16/881973
[patent_app_country] => US
[patent_app_date] => 2020-05-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 6166
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 154
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16881973
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/881973 | Compositions comprising lignocellulosic byproducts for tire ballasts and associated methods | May 21, 2020 | Issued |
Array
(
[id] => 20264338
[patent_doc_number] => 12435315
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-10-07
[patent_title] => Generating dorsal foregut, and anterior domain, endoderm cells
[patent_app_type] => utility
[patent_app_number] => 17/609954
[patent_app_country] => US
[patent_app_date] => 2020-05-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 25
[patent_no_of_words] => 8210
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 159
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17609954
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/609954 | Generating dorsal foregut, and anterior domain, endoderm cells | May 21, 2020 | Issued |